AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...
Low-pass Whole Genome Profile (chr 1-22) of single CTC (upper panel) and WBC (lower panel) isolated with DEPArray™ Technology from a patient with Lung Adenocarcinoma. Ploidy values are indicated ...
The expansion of clones with distinct SERPINA1 somatic mutants in the livers of alpha-1 antitrypsin deficiency (A1AT) patients is consistent with convergent evolution. These variants interfere ...
Microglia are brain-resident macrophages playing pivotal roles in CNS development and homeostasis. Yet, the cellular and molecular basis governing microglia maintenance ...
Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.
After hours: March 18 at 7:45:43 PM EDT Loading Chart for ILMN ...
The findings shed new light on the role of SATB1 in genome organization and will ... (Capital letters represent Illumina sequence and lower-case letters represent linker sequence). For sequencing, the ...
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback